These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 2918943)
41. Effects of complement activation by hemodialysis membranes. Cheung AK; Henderson LW Am J Nephrol; 1986; 6(2):81-91. PubMed ID: 3518458 [No Abstract] [Full Text] [Related]
42. Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis. Ward RA; Schaefer RM; Falkenhagen D; Joshua MS; Heidland A; Klinkmann H; Gurland HJ Nephrol Dial Transplant; 1993; 8(1):47-53. PubMed ID: 8381935 [TBL] [Abstract][Full Text] [Related]
43. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes. Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869 [TBL] [Abstract][Full Text] [Related]
44. Complement activation during hemodialysis. Comparison of polysulfone and cuprophan membranes. Stannat S; Bahlmann J; Kiessling D; Koch KM; Deicher H; Peter HH Contrib Nephrol; 1985; 46():102-8. PubMed ID: 3874042 [No Abstract] [Full Text] [Related]
45. Production of interleukin 1 receptor antagonist and interleukin 1 during haemodialysis with cellulose membranes. Frith SE; Hoenich NA; Redfern CP; Goodship TH Int J Artif Organs; 1994 Sep; 17(9):478-87. PubMed ID: 7890436 [TBL] [Abstract][Full Text] [Related]
46. A comparison of dialysers with low-flux membranes: significant differences in spite of many similarities. Ward RA; Buscaroli A; Schmidt B; Stefoni S; Gurland HJ; Klinkmann H Nephrol Dial Transplant; 1997 May; 12(5):965-72. PubMed ID: 9175051 [TBL] [Abstract][Full Text] [Related]
47. Removal of plasma porphyrins with high-flux hemodialysis in porphyria cutanea tarda associated with end-stage renal disease. Carson RW; Dunnigan EJ; DuBose TD; Goeger DE; Anderson KE J Am Soc Nephrol; 1992 Mar; 2(9):1445-50. PubMed ID: 1627767 [TBL] [Abstract][Full Text] [Related]
48. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes. Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054 [TBL] [Abstract][Full Text] [Related]
49. Performance and biocompatibility of a new hemodialysis membrane. von Herrath D; Dati F; Pelzer H; Hartenstein K; Kutschera D; Schaefer K Blood Purif; 1986; 4(1-3):151-8. PubMed ID: 3637111 [TBL] [Abstract][Full Text] [Related]
50. Leukocyte C5a receptor modulation during hemodialysis. Lewis SL; Van Epps DE; Chenoweth DE Kidney Int; 1987 Jan; 31(1):112-20. PubMed ID: 2951551 [TBL] [Abstract][Full Text] [Related]
51. On complement net generation in fast hemodialysis: are high blood flow rates bioincompatible? Skroeder NR; Kjellstrand P; Holmquist B; Kjellstrand CM; Jacobson SH Am J Kidney Dis; 1995 Jun; 25(6):896-903. PubMed ID: 7771486 [TBL] [Abstract][Full Text] [Related]
52. Clinical study of high-flux cuprammonium rayon hemodialysis membranes. Opatrný K; Sulková S; Lopot F; Vít L; Válek A; Opatrný K Artif Organs; 1993 Dec; 17(12):971-6. PubMed ID: 8110071 [TBL] [Abstract][Full Text] [Related]
53. [The effect of hemodialysis on the virgin CD45RA+, CD45RO- and memory CD45RO+, CD45RA- lymphocyte count in patients with chronic renal failure]. Szydłowska I; Zukowska-Szczechowska E; Grzeszczak W Pol Arch Med Wewn; 2000; 103(3-4):169-77. PubMed ID: 11236244 [TBL] [Abstract][Full Text] [Related]
54. Plasma levels of main granulocyte components in patients dialyzed with polycarbonate and cuprophan membranes. Hörl WH; Riegel W; Schollmeyer P Nephron; 1987; 45(4):272-6. PubMed ID: 3035392 [TBL] [Abstract][Full Text] [Related]
55. Biocompatibility of hemodialysis membranes: evaluation in an ovine model. Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041 [TBL] [Abstract][Full Text] [Related]
56. Effect of permeability on indices of haemodialysis membrane biocompatibility. Masaki T; Gilson J; Leypoldt JK; Cheung AK Nephrol Dial Transplant; 1999 May; 14(5):1176-81. PubMed ID: 10344358 [TBL] [Abstract][Full Text] [Related]
57. Acute changes in C3a and C5a in an anaphylactoid reaction in hemodialysis patients. Suzuki Y; Uchida J; Tsuji H; Kuzuhara K; Hara S; Nihei H; Ogura Y; Otsubo O; Mimura N Tohoku J Exp Med; 1987 May; 152(1):35-45. PubMed ID: 3497472 [TBL] [Abstract][Full Text] [Related]
58. [Plasma levels of complement fragments during hemodialysis in patients with chronic renal failure]. Ueda M; Deguchi M; Takemura S; Kasamatsu Y; Yanagida K; Fukuda W; Okamoto M; Onodera H; Sugino S; Kondo M Nihon Jinzo Gakkai Shi; 1990 Jan; 32(1):19-24. PubMed ID: 2348571 [TBL] [Abstract][Full Text] [Related]
59. Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers. Hörl WH; Riegel W; Schollmeyer P; Rautenberg W; Neumann S Clin Nephrol; 1986 Jun; 25(6):304-7. PubMed ID: 3015463 [TBL] [Abstract][Full Text] [Related]
60. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis]. Germin Petrović D Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]